What is Global Peripheral Intervention Drug-Eluting Devices Market?
The Global Peripheral Intervention Drug-Eluting Devices Market is a specialized segment of the healthcare industry that focuses on the development and distribution of drug-eluting devices used in peripheral interventions. These devices are designed to deliver medication directly to the affected area, reducing the need for systemic drug administration and improving patient outcomes. The market encompasses a wide range of devices, including drug-eluting stents and balloons, which are used in various medical procedures to treat conditions such as peripheral artery disease. The global market for these devices is driven by factors such as the increasing prevalence of peripheral vascular diseases, advancements in technology, and the growing demand for minimally invasive procedures.
Drug-Eluting Balloons, Drug-Eluting Stents in the Global Peripheral Intervention Drug-Eluting Devices Market:
Drug-Eluting Balloons (DEBs) and Drug-Eluting Stents (DES) are two key products in the Global Peripheral Intervention Drug-Eluting Devices Market. DEBs are used in angioplasty procedures to open up blocked or narrowed blood vessels. They are coated with a drug that helps prevent the vessel from narrowing again. DES, on the other hand, are small mesh tubes that are used to treat narrowed or weakened arteries. They are coated with a drug that helps prevent the artery from becoming blocked again. Both DEBs and DES have been shown to improve patient outcomes by reducing the risk of restenosis (re-narrowing of the blood vessel) and the need for repeat procedures. The use of these devices is becoming increasingly common in the treatment of peripheral vascular diseases, driving growth in the global market.
Plain Old Balloon Angioplasty (POBA), Percutaneous Transluminal Angioplasty (PTA) in the Global Peripheral Intervention Drug-Eluting Devices Market:
The Global Peripheral Intervention Drug-Eluting Devices Market plays a crucial role in the treatment of various vascular conditions through procedures such as Plain Old Balloon Angioplasty (POBA) and Percutaneous Transluminal Angioplasty (PTA). POBA is a procedure in which a small balloon is inflated within a blocked artery to open it up and improve blood flow. PTA, on the other hand, is a minimally invasive procedure used to open up blocked peripheral arteries. Both procedures can be enhanced with the use of drug-eluting devices, which deliver medication directly to the affected area to prevent the artery from becoming blocked again. The use of these devices in POBA and PTA procedures is becoming increasingly common, contributing to the growth of the global market.
Global Peripheral Intervention Drug-Eluting Devices Market Outlook:
Looking at the market outlook, the global pharmaceutical market is projected to reach a value of 1475 billion USD in 2022, representing a compound annual growth rate (CAGR) of 5% over the next six years. This growth is driven by factors such as the increasing prevalence of chronic diseases, advancements in medical technology, and the growing demand for effective treatment options. In comparison, the chemical drug market is expected to grow from 1005 billion USD in 2018 to 1094 billion USD in 2022. This growth is driven by factors such as the increasing demand for generic drugs, advancements in chemical drug development, and the growing prevalence of diseases that require chemical drug treatment.
| Report Metric | Details |
| Report Name | Peripheral Intervention Drug-Eluting Devices Market |
| CAGR | 5% |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, Biosensors International Group Ltd., C.R. Bard, Inc., Abbott, The Lubrizol Corporation, Terumo Corporation |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
